Breaking News

Alexza Appoints Quality VP

April 17, 2014

Brown brings 20 years of industry experience

Winston R. Brown, Jr. has been appointed vice president of Quality at Alexza Pharmaceuticals, Inc. Mr. Brown will be responsible for Quality Assurance, Quality Control and Quality Systems. He has more than 20 years of experience in global quality, regulatory compliance and development operations working with biopharmaceutical, medical device, and nutritional companies. 
Mr. Brown joins the company from Alcon Research, a division of Novartis, where he served as global head of Quality R&D, Pharmaceuticals, Biologics, and Vision Care Devices. Mr. Brown previously served as executive director, Global Quality Compliance for Baxter Healthcare International from 2009 to 2011. Mr. Brown also held positions with Bausch & Lomb as director of Site Quality, Vision Care-Sterile Ophthalmic Solutions, and held multiple leadership positions in quality systems/compliance, regulatory affairs, and process validation with Holopack Pharmaceuticals, USA and J&J Consumer Pharmaceuticals.
"We are pleased to welcome Winston to our team," said Robert A. Lippe, executive vice president, Operations and chief operations officer at Alexza. "Winston brings extensive quality program expertise coupled with strong operational leadership experience to our company, at a time of exciting growth in both scale and scope.  We look forward to his contributions in support of our efforts with the global ADASUVE launch and in expanding our candidate pipeline."

Related Contract Manufacturing:

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks